Mechanism of ozone alleviation of malignant ascites in hepatocellular carcinoma through inhibition of NETs
F. Han, C. M. Mu, K. Bian, Z. Mu, Q. Duan, J. Y. Guo, J. Ma, L. Jin, W. Liu, F. Chen
Abstract
Malignant ascites in hepatocellular carcinoma is usually a sign of advanced disease and poor prognosis and is also thought to be associated with chronic inflammation mediated by neutrophil extracellular trap networks (NETs). Whereas ozone, a strong oxidant, has significant antibacterial and anti-inflammatory effects, its effectiveness in treating malignant liver ascites is unclear.cOzone showed significant anti-peritoneal fluid production properties in H22 tumor-bearing mice, and ozone reduced peritoneal fluid production by activating AMPK and up-regulating SR-A phagocytosis damage-associated molecular patterns (DAMPs) to reduce the production of NETs. This suggests that ozone could be used as a new drug for the treatment of malignant ascites in hepatocellular carcinoma.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Neutrophil extracellular trap formation correlates with improved overall survival in ovarian cancer
- Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis
M. Inoue, M. Enomoto, … S. V. Bratman·bioRxiv·Feb 28, 2018
- Malignant ascites enhance γδ T cell cytotoxicity towards ovarian cancer via modulating chemokines secretion from the cancer cells that recruits γδ T cells
Zhanqun Yang, Ying Liu, … Long Chen·bioRxiv·Mar 5, 2025
- Ascitic fluid protects against ferroptosis and enables the peritoneal spread of ovarian cancer
Yasaman Setayeshpour, S Chen, … Jen‐Tsan Chi·Nature CommunicationsPeer-reviewed·May 11, 2026
- Ascites in malignant ovarian cancer confer ovarian cancer cells chemoresistance to platinum. Combination treatment with crizotinib and 2-hydroxyestradiol restores platinum sensitivity.
Y. K. Carmi, A. Agbarya, … J. Mahajna·bioRxiv·Sep 24, 2023
- Intraperitoneal activation of myeloid cells clears ascites and reveals IL27-dependent regression of metastatic ovarian cancer
Brennah Murphy, Taito Miyamoto, … Nan Zhang·The Journal of Experimental MedicinePeer-reviewed·Oct 16, 2024